June 8, 2017August 24, 2022
Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

The MEK inhibitor Mekinist (trametinib) is to be tested in combination with Opdivo (nivolumab) — or Opdivo plus Yervoy (ipilimumab) — in colorectal cancer ... Read more
June 6, 2017
Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Certain patients who underwent surgery for lymph-node positive colon cancer (stage 3) may require only three months of chemotherapy after surgery ... Read more
June 1, 2017June 1, 2017
Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

The MEK inhibitor binimetinib will soon be tested in combination with Opdivo (nivolumab) plus Yervoy (ipilimumab) in colorectal cancer patients ... Read more
May 30, 2017
PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

Trovagene’s PCM-075 therapy for several blood cancers and solid tumors, including colon cancer, proved safe in a Phase 1 clinical ... Read more
May 25, 2017May 25, 2017
FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Colorectal cancer patients with unresectable or metastatic tumors bearing a genetic feature — microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) — ... Read more
May 23, 2017
Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Overweight boys have a higher risk of developing colon cancer in adulthood, but if they lose the extra pounds by ... Read more
May 18, 2017May 18, 2017
Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Tom Marsilje, who survived stage IV colorectal cancer (CRC), has joined forces with New York-based Fight Colorectal Cancer to help patients search for ... Read more
May 16, 2017
Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

The Colon Cancer Coalition, a nonprofit organization that encourages grassroots efforts to promote colon cancer awareness and screening, is partnering ... Read more
May 11, 2017
Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

A new European project aims to develop an innovative endoscope device that can detect and diagnose colorectal cancer in its early ... Read more
May 9, 2017
Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

People who eat healthy, exercise, and do not smoke are less likely to report a personal history of colorectal cancer ... Read more
May 4, 2017May 4, 2017
RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

Small molecule compounds known as RLR agonists, being developed by Kineta to treat colon cancer, were seen to kill cancer ... Read more
May 2, 2017May 2, 2017
New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research

MIT researchers using the CRISPR-Cas9 genome editing and organoid technology have developed a new mouse model with a cancer that ... Read more

April 21, 2015April 21, 2015

DiaCarta and University of Potsdam Collaborate on Novel Early Colon Cancer Detection Test

California-based molecular diagnostics company DiaCarta Inc. and the University of Potsdam in Germany have recently announced an exclusive license agreement for the development and commercialization of a non-invasive diagnostic test for early detection ... Read more

April 20, 2015April 20, 2015

Exercise is Beneficial for Colorectal Cancer Survivors, According to Study

According to two recent studies conducted by an American and Dutch team and published in the Journal of Cancer Survivorship, exercise is beneficial for colon and prostate cancer survivors. In the ... Read more

April 17, 2015April 18, 2015

“Nontoxic” Salmonella Kills Colon Cancer Cells

Colon cancer cells are no match for Salmonella enterica. However, there is risk for using Salmonella as part of cancer therapy, as the microbe wreaks havoc on the human body. It ... Read more

April 16, 2015April 16, 2015

New Protein Implicated in Colon Cancer Metabolism Upon Excess of Nutrients

A new study published last week in the Developmental Cell journal offers new possibilities of therapy development for diseases such as colon cancer and diabetes mellitus. Senior author Nabil Djouder and his team from ... Read more

April 15, 2015April 15, 2015

Researchers Target Protein To Stop Spread Of Colon Cancer

Researchers have developed the podocalyxin antibody, demonstrating that it slows both tumor growth and spread by comparing cancer metastases with control samples. These findings were recently published in the Breast Cancer Research journal and may lead to major developments ... Read more

April 14, 2015April 14, 2015

mTOR Inhibitors Revealed To Be Strong Anti-Colon Cancer Agents

Colon cancer is often associated with the mammalian target of rapamycin (mTOR), a serine/threonine kinase activated in a range of cellular activities such as growth, proliferation, and migration. A new ... Read more

April 13, 2015April 13, 2015

Pancreatic Cancer Drug Works Against Accumulation of Malignant Ascites Fluid in Colon Cancer Patients

Research supported by PharmaCyte Biotech, Inc., a biotechnology company developing treatments for cancer patients, determined that the company’s pancreatic cancer treatment is able to reduce malignant ascites’ fluid accumulation. Ascites consist of a fluid build-up in ... Read more

April 10, 2015April 10, 2015

Imatinib Inhibits EphB Abl Signaling Pathway and Suppresses Colorectal Cancer

Researchers from Karolinska Institutet in Sweden and Nanyang Technological University in Singapore showed that the drug Imatinib, a tyrosine kinase inhibitor used in leukemia, can inhibit the development of intestinal ... Read more

April 9, 2015April 9, 2015

Overweight Girls More Likely to Develop Colorectal Cancer

Overweight children and youngsters may have a higher risk of developing colorectal cancer later in life, according to a study recently published in Cancer Epidemiology Biomarkers and Prevention. The conclusions mainly involved women, ... Read more

April 7, 2015April 7, 2015

Fasting Combined With Less-Toxic Drugs Effective Alternative to Chemotherapy

A multinational collaboration between the University of Southern California, Lizzia Raffaghello at the G. Gaslini Institute in Italy and the laboratories of Alessio Nencioni at University of Genova, showed that a less-toxic class of ... Read more

April 6, 2015April 8, 2015

Study Points Out New Role For Gene In Colon Cancer Suppression

A novel function in a previously known gene may help cells divide normally, but its absence might cause tumors, particularly in colon cancer. These are the results from a team of The ... Read more

April 6, 2015April 6, 2015

Clinical Practice Guidelines on Molecular Marker Tests for Colorectal Cancer Open to Public Comment

An expert panel recently released a clinical practice guideline draft for the assessment of molecular markers in patients with primary or metastatic colorectal cancer. The document is entitled “Guideline on the ... Read more

Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research